Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
SRTS

Sensus Healthcare (SRTS) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $2.95 -0.7% on the day -13.2% over 12 months 52-week range $2.69 – $5.30

Share price and insider trades

SRTS closeInsider buyInsider sale
23456NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $5,010 on 2026-05-12 · Eric SachettaBought $7,620 on 2026-02-24 · Eric SachettaBought $11,250 on 2025-11-13 · Eric SachettaBought $21,329 on 2025-11-11 · Michael SardanoBought $22,750 on 2026-08-21 · Eric SachettaBought $27,510 on 2025-11-21 · Eric SachettaBought $31,939 on 2026-08-26 · Eric SachettaBought $34,742 on 2026-08-27 · Eric SachettaBought $96,656 on 2026-08-31 · Eric SachettaBought $104,550 on 2025-11-18 · Joseph C Sardano, Michael SardanoBought $112,765 on 2026-08-24 · Eric SachettaBought $129,127 on 2026-08-28 · Eric SachettaBought $135,520 on 2026-08-20 · Eric Sachetta, Joseph C Sardano
Bought, 12 months$703K
Sold, 12 months$0
Insiders buying2
Insiders selling0

Sensus Healthcare insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $703K and 0 sold $0 of SRTS stock on the open market.

SRTS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $165K bought (11 trades)$165KQ4 2025Q1 2026: $8K bought (1 trades)$8KQ1 2026Q2 2026: $5K bought (1 trades)$5KQ2 2026Q3 2026: $563K bought (8 trades)$563KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$563K8—0
Q2 2026$5K1—0
Q1 2026$8K1—0
Q4 2025$165K11—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$48.6MMedical Devices
Profit margin-88.4%Revenue growth -68.7%
Volume vs. 50-day0.6×Last 5 sessions
Insiders' paper profit−$106KOn all tracked purchases -14.3%

Summary

Over the past 12 months, 2 Sensus Healthcare, Inc. insiders reported open-market purchases totaling $703K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Eric Sachetta (Director) has the highest Insider Score at 38.

SRTS stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 31SEC Eric SachettaDirector Buy 37,537267,480 held (+16%) $3.44 $129K -14.2% 38
Aug 31SEC Eric SachettaDirector Buy 27,304294,784 held (+10%) $3.54 $97K -16.7% 38
Aug 28SEC Eric SachettaDirector Buy 10,925229,943 held (+5%) $3.18 $35K -7.2% 38
Aug 28SEC Eric SachettaDirector Buy 9,708219,018 held (+5%) $3.29 $32K -10.3% 38
Aug 25SEC Eric SachettaDirector Buy 34,697209,310 held (+20%) $3.25 $113K -9.2% 38
Aug 24SEC Eric SachettaDirector Buy 24,000167,613 held (+17%) $3.13 $75K -5.8% 38
Aug 24SEC Joseph C SardanoCEO Buy 20,0001,220,293 held (+2%) $3.02 $60K -2.3% —
Aug 24SEC Eric SachettaDirector Buy 7,000174,613 held (+4%) $3.25 $23K -9.2% 38
May 12SEC Eric SachettaDirector Buy 1,500143,613 held (+1%) $3.34 $5K -11.7% 38
Feb 26SEC Eric SachettaDirector Buy 2,000142,113 held (+1%) $3.81 $8K -22.6% 38
Nov 21SEC Eric SachettaDirector Buy 7,000140,113 held (+5%) $3.93 $28K -24.9% 38
Nov 20SEC Eric SachettaDirector Buy 2,500133,113 held (+2%) $4.50 $11K -34.4% 38
Nov 19SEC Joseph C SardanoCEO Buy 25,0001,200,293 held (+2%) $4.03 $101K -26.8% —
Nov 19SEC Michael SardanoGeneral Counsel, President Buy 1,000118,839 held (+1%) $3.80 $4K -22.4% —
Nov 18SEC Michael SardanoGeneral Counsel, President Buy 1,000117,839 held (+1%) $4.26 $4K -30.8% —
Nov 18SEC Michael SardanoGeneral Counsel, President Buy 766new position $4.27 $3K -30.9% —
Nov 18SEC Michael SardanoGeneral Counsel, President Buy 2341,000 held (+31%) $4.34 $1K -32.0% —
Nov 13SEC Michael SardanoGeneral Counsel, President Buy 1,000117,839 held (+1%) $4.26 $4K -30.8% —
Nov 13SEC Michael SardanoGeneral Counsel, President Buy 766118,605 held (+1%) $4.27 $3K -30.9% —
Nov 13SEC Michael SardanoGeneral Counsel, President Buy 234118,839 held (+0%) $4.24 $992 -30.4% —
Nov 12SEC Michael SardanoGeneral Counsel, President Buy 1,000117,839 held (+1%) $4.26 $4K -30.8% —

Insiders at Sensus Healthcare, Inc.

InsiderBoughtSoldLast filingScore
Eric SachettaDirector $554K — Aug 31, 2026 38
Joseph C SardanoCEO $161K — Aug 24, 2026 —
Michael SardanoGeneral Counsel, President $25K — Nov 19, 2025 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

SRTS stock: common questions

Are Sensus Healthcare, Inc. insiders buying SRTS stock?

In the past 12 months, 2 insiders reported open-market purchases of SRTS worth $703K. The latest was Director Eric Sachetta bought $129K of SRTS at $3.44 — largest purchase by this insider in our records.

Are Sensus Healthcare, Inc. insiders selling SRTS stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is SRTS's 52-week range?

Over the past year SRTS has traded between $2.69 and $5.30. It last closed at $2.95 on Oct 9, 2026.